Froome urine test result in Vuelta double WADA threshold for asthma medication
ByPA Sport
Published 13/12/2017 at 07:26 GMT
Chris Froome has vowed to provide whatever information is required by the UCI about his use of medication for asthma during the 2017 Vuelta a Espana after a urine test revealed a concentration of Salbutamol double the WADA threshold.
Team Sky said in a statement that Froome experienced "acute asthma symptoms" during the final week of the Vuelta and increased his dosage of Salbutamol, within permissible limits, on doctor's advice.
The four-time Tour de France winner conducted a urine test on September 7 which revealed a concentration of Salbutamol of 2,000 nanograms, twice the WADA threshold of 1,000.
The Team Sky statement said the "use of permissible dosages of Salbutamol can sometimes result in elevated urinary concentrations, which require explanation".
Froome said: " The UCI is absolutely right to examine test results and, together with the team, I will provide whatever information it requires."
Join 3M+ users on app
Download
Scan me
Related Topics
Share this article
Advertisement
Advertisement